anmelden
OMX Copenhagen PI
1.285,53
PKT
-18,08
PKT
-1,39
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Copenhagen PI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.08.17 | Novo Nordisk Neutral | Citigroup Corp. | |
| 11.08.17 | Novo Nordisk Neutral | Citigroup Corp. | |
| 10.08.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 10.08.17 | Novo Nordisk buy | UBS AG | |
| 10.08.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 10.08.17 | Novo Nordisk Underweight | Barclays Capital | |
| 10.08.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 10.08.17 | Novo Nordisk Reduce | HSBC | |
| 09.08.17 | Novo Nordisk Hold | S&P Capital IQ | |
| 04.08.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 01.08.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 01.08.17 | Novo Nordisk buy | UBS AG | |
| 26.07.17 | Novo Nordisk buy | UBS AG | |
| 21.07.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 07.07.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 30.06.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 27.06.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 26.06.17 | Novo Nordisk Neutral | Citigroup Corp. | |
| 21.06.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 19.06.17 | Novo Nordisk Neutral | Citigroup Corp. | |
| 19.06.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 16.06.17 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 14.06.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 12.06.17 | Novo Nordisk buy | UBS AG | |
| 26.05.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 24.05.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 12.05.17 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 04.05.17 | Novo Nordisk buy | UBS AG | |
| 04.05.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 04.05.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 04.05.17 | Novo Nordisk Reduce | HSBC | |
| 03.05.17 | Novo Nordisk Hold | S&P Capital IQ | |
| 03.05.17 | Novo Nordisk buy | UBS AG | |
| 28.04.17 | Novo Nordisk buy | UBS AG | |
| 11.04.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 05.04.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 03.04.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 23.03.17 | Novo Nordisk Sell | Société Générale Group S.A. (SG) | |
| 09.03.17 | Novo Nordisk buy | UBS AG | |
| 08.03.17 | Novo Nordisk Underweight | Barclays Capital |